Does fear of cancer recurrence differ between cancer types? A study from the population‐based PROFILES registry
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Objective: Knowledge of factors associated with fear of cancer recurrence (FCR) may inform intervention development and improve patient care. The aims were (1) to compare FCR severity between cancer types and (2) to identify associations between FCR, demographics, medical characteristics, information provision and health‐related quality of life. Methods: Cross‐sectional data were obtained from the Patient Reported Outcomes Following Initial Treatment and Long‐Term Evaluation of Survivorship registry. We included stage I and II survivors diagnosed with melanoma (n = 469), colorectal cancer (n = 861), endometrial cancer (n = 688), thyroid cancer (n = 218), Hodgkin (n = 103) and non‐Hodgkin lymphoma (n = 276). Cancer survivors completed questionnaires on FCR (Impact of Cancer scale – Health Worries subscale), satisfaction with information provision (European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire (EORTC‐QLQ) INFO25, satisfaction scale) and health‐related quality of life (EORTC‐QLQ C30, Short Form 36‐item). Results: A total of 2615 survivors completed the Impact of Cancer scale – Health Worries subscale. No significant differences in FCR severity were found between any of the cancer types (p = 0.063). A younger age, female gender, stage II disease, a shorter time since diagnosis, scheduled follow‐up appointments and comorbidity were associated with higher FCR (p < 0.01). Satisfaction with information provision was negatively correlated with FCR severity (r = −0.16, p < 0.05). Demographic and medical factors accounted for 6% of explained variance in FCR. The full model, also including health‐related quality of life, explained 15% and 19%, respectively. Conclusion: Fear of cancer recurrence seems to be a universal concern of cancer survivors rather than a cancer type‐specific problem. Gender, age and medical factors were identified as risk factors. Copyright © 2015 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Muller, M., Cohen, P. D. A., Essink-Bot, M.-L., Fekkes, M., Sanderman, R., Sprangers, M. A. G., te Velde, A., & Verrips, E. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00097-3 · Cited by 2,276
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
Simard, S., Thewes, B., Humphris, G., Dixon, M., Hayden, C., Mireskandari, S., & Ozakinci, G. (2013) · Journal of Cancer Survivorship · doi:10.1007/s11764-013-0272-z · Cited by 1,217 · cited 6×
“Only limited evidence was found for medical factors such as disease stage, treatment modality and physical comorbidity [2,3,10].”
BackgroundResultInfluentialSimard, S., & Savard, J. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0444-y · Cited by 608 · cited 4×
“However, the items are fairly comparable with items from more commonly used FCR measures, such as the Cancer Worry Scale and the Fear of Cancer Recurrence Inventory [6,29] and have good face validity as well.”
BackgroundMethodInfluentialHusson, O., Mols, F., & van de Poll-Franse, L. V. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq413 · Cited by 535 · cited 1×
“Still, anxiety has also been associated with inhibition of information processing leading to difficulty understanding medical information and less satisfaction [26].”
BackgroundKoch, L., Jansen, L., Brenner, H., & Arndt, V. (2013) · Psycho-Oncology · doi:10.1002/pon.3022 · Cited by 511 · cited 5×
“Only limited evidence was found for medical factors such as disease stage, treatment modality and physical comorbidity [2,3,10].”
BackgroundInfluentialDeimling, G. T., Bowman, K. F., Sterns, S., Wagner, L. J., & Kahana, B. (2006) · Psycho-Oncology · doi:10.1002/pon.955 · Cited by 496 · cited 1×
“Prostate, breast, colorectal and uterine cancer survivors reported similar proportions of FCR [8,9].”
BackgroundVickberg, S. M. J. (2003) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm2501_03 · Cited by 468
Factors reported to influence fear of recurrence in cancer patients: a systematic review
Crist, J. V., & Grunfeld, E. A. (2013) · Psycho-Oncology · doi:10.1002/pon.3114 · Cited by 431
Fear of cancer recurrence: specific profiles and nature of intrusive thoughts
Simard, S., Savard, J., & Ivers, H. (2010) · Journal of Cancer Survivorship · doi:10.1007/s11764-010-0136-8 · Cited by 229 · cited 1×
“Prostate cancer survivors experienced the lowest FCR, whereas FCR levels in breast, colorectal and lung cancer survivors were comparable [6,7].”
Backgroundthe FCR Study Advisory Committee, Thewes, B., Butow, P., Bell, M. L., Beith, J., Stuart-Harris, R., Grossi, M., Capp, A., & Dalley, D. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-011-1371-x · Cited by 213
Research works printed but not linked: 16
- 10.1002/pon.1305 · DOI
- 10.1016/j.ejca.2011.04.034 · DOI · Paper page
- 10.1007/s11764-009-0087-0 · DOI
- Ware JR, 1993, SF‐36 Health Survey: Manual and Interpretation Guide
- 10.1093/jnci/85.5.365 · DOI · Paper page
- Fayers PM, 2001, The EORTC QLQ‐C30 Scoring Manual
- 10.1016/j.ejca.2010.06.118 · DOI · Paper page
- 10.1002/art.10993 · DOI · Paper page
- 10.1002/cncr.24544 · DOI
- 10.1016/j.pec.2005.01.002 · DOI
- Leventhal H, 1980, The Commonsense Representation of Illness Danger, 7
- 10.1002/(SICI)1099-1611(199706)6:2<95::AID-PON250>3.0.CO;2-B · doi:10.1002/(sici)1099-1611(199706)6:2<95::aid-pon250>3.0.co;2-b
- 10.1007/s10549-011-1551-x · DOI · Paper page
- 10.1002/pon.931 · DOI · Paper page
- 10.1002/pon.894 · DOI · Paper page
- 10.1097/NCC.0b013e3182813a17 · DOI · Paper page
Cited by
Almeida, S. N., Elliott, R., Silva, E. R., & Sales, C. M. D. (2019) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.12.001 · Cited by 116
Fear of Progression in Cancer Patients and Survivors
Dinkel, A., & Herschbach, P. (2018) · Recent Results in Cancer Research · doi:10.1007/978-3-319-64310-6_2 · Cited by 114
Factors Correlated With Fear of Cancer Recurrence in Cancer Survivors: A Meta-analysis
Zhang, X., Sun, D., Qin, N., Liu, M., Jiang, N., & Li, X. (2022) · Cancer Nursing · doi:10.1097/ncc.0000000000001020 · Cited by 90
Fear of cancer recurrence and its predictors among cervical cancer survivors
Hanprasertpong, J., Geater, A., Jiamset, I., Padungkul, L., Hirunkajonpan, P., & Songhong, N. (2017) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2017.28.e72 · Cited by 86
“[17] study that FCR seems to be a universal concern of cancer survivors rather than a cancer type-specific problem.”
BackgroundInfluentialPang, C., & Humphris, G. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.640866 · Cited by 59
Burm, R., Thewes, B., Rodwell, L., Kievit, W., Speckens, A., van de Wal, M., & Prins, J. (2019) · BMC Cancer · doi:10.1186/s12885-019-5615-3 · Cited by 55
“FCR seems to be a universal concern of cancer survivors rather than a cancer type-specific problem, estimates of FCR did not differ by cancer types [12].”
Self-citationSmith, A. ‘., Wu, V. S., Lambert, S., Lamarche, J., Lebel, S., Leske, S., & Girgis, A. (2022) · Journal of Cancer Survivorship · doi:10.1007/s11764-021-01109-4 · Cited by 48
Current directions in research and treatment of fear of cancer recurrence
Sharpe, L., Thewes, B., & Butow, P. (2017) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0000000000000288 · Cited by 37
Translation and validation of the Dutch version of the Fear of Cancer Recurrence Inventory (FCRI-NL)
van Helmondt, S. J., van der Lee, M. L., & de Vries, J. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.09.001 · Cited by 31
Emotion-focused therapy for fear of cancer recurrence: A hospital-based exploratory outcome study.
Almeida, S. N., Elliott, R., Silva, E. R., & Sales, C. M. D. (2022) · Psychotherapy · doi:10.1037/pst0000389 · Cited by 12
Metadata
- Authors
- van de Wal, M., van de Poll‐Franse, L., Prins, J., & Gielissen, M.
- Venue
- Psycho-Oncology
- Publisher
- Wiley
- Published
- 2015-10-14
- Volume
- 25
- Issue
- 7
- Pages
- 772-778
- ISSN
- 1057-9249 (ISSN-L)
- 1099-1611
- OpenAlex
- W1953658494
- Cited by
- 102
- References
- 12
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.